focus -WSS

focus

author：explore 2025-09-11 10:30:28 - browse：413

SAN DIEGO — Months after announcing plans to cut costs by $100 million, DNA sequencing giant Illumina has begun to lay off 10% of its research and development team, according to internal emails obtained and reviewed by STAT.

The layoffs, which began last Wednesday, impact research teams across the company’s California sites in San Diego and Foster City, as well as locations in Madison, Wisconsin; Singapore; and the United Kingdom. Alex Aravanis, the company’s chief technology officer, noted in an internal message that these cuts affect a tenth of research and development staff. The company’s also planning to shut down all lab-based research and development work in Foster City, according to a note from Steve Barnard, vice president of technology development.

Barnard’s note mentions that all affected employees have already been notified. And a separate message from interim CEO Charles Dadswell makes clear last week’s layoffs won’t be the last.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Primary care physicians play key roles in Alzheimer's management

WSS

Interest rates are at a 22

Why the world’s most expensive drug might be worth the price

Readout Newsletter: Merck, Vertex, and Viking updates

‘We were in the air.’ Mississippi family recounts surviving tornado that tore mobile home apart

VC firm RA Capital starts a new synthetic biology incubator

Biden to sign 'historic' executive order on how US military handles sexual assault cases

knowledge

focus

explore

Medicare proposal to cover medical devices draws a mixed reaction

Why the world’s most expensive drug might be worth the price

Heart attack and stroke risk calculators need revising

An outrageous hospital charge: I paid $710 for an hour of babysitting

Trump demands the U.S. pay no more for drugs than other countries … again

Merck drug for rare lung condition set for approval in U.S.

Continuity nursing helped my family in our darkest PICU moments

Ending health disparities requires full federal government, panel says

In age of alternative facts, a scholarly course on calling out crap

Trader Joe's recalls 10K cases of broccoli cheddar soup over potential foreign material

leisure time

Steward Health Care has deal to sell doctor network to UnitedHealth

Why the world’s most expensive drug might be worth the price

McConnell had minor fall 2 weeks ago, uses wheelchair periodically to get around: Sources

Scientists boost immune system in aging mice by making it youthful

Vertex Pharmaceuticals may move headquarters in Boston

Trump allegedly attempted to have surveillance video deleted: Special Counsel

focus

entertainment

leisure time

focus